Pfizer and German partner BioNTech announced the launch of their late-stage trial to test their COVID-19 vaccine in 30,000 people on Monday – hours after Moderna announced its own late-stage, large trial.
Via: Pfizer kicks off 30,000-person trial for its coronavirus vaccine
Categories: English News